NASDAQ: NLTX       Neoleukin Therapeutics Inc
Last Price Today's Change   Day's Range   Trading Volume
2.92   -0.05 (1.68%)  2.91 - 3.002  25,400


Avg Volume (4 weeks):40,638
4 Weeks Range:2.53 - 3.15
4 Weeks Price Volatility (%):
52 Weeks Range:2.53 - 4.23
52 Weeks Price Volatility (%):
Average Price Target:-


No recent Headlines for this stock.

Business Background

Nile Therapeutics, Inc. (Nile) is a development-stage biopharmaceutical company in the business of commercially developing products for the treatment of cardiovascular diseases. The Company's product CD-NP, a chimeric natriuretic peptide is in Phase II clinical studies for the treatment of heart failure. The Company is developing CD-NP for an initial indication of acute decompensated heart failure (ADHF). The Company is also developing CU-NP, a pre-clinical rationally designed natriuretic peptide that consists of amino acid chains identical to those produced by the human body, specifically the ring structure of C-type natriuretic peptide (CNP), and the N- and C-termini of Urodilatin (URO).

  Be the first to like this.


4486  3499  717  224 

Top 10 Active Counters
 CHK 0.702+0.032 
 FCEL 0.81+0.265 
 AMD 37.52+0.81 
 EEM 42.76-0.33 
 ET 11.16-0.50 
 SPY 309.10+0.10 
 GE 11.29-0.13 
 BAC 32.79-0.30 
 DIS 148.72+10.14 
 XLF 29.61-0.19 
Partners & Brokers